The results showed that rutin exhibited a strong inhibitory effect on FXR/RXR, DPP4, JAK2, and ACE (Figure 4D), suggesting its potential as a therapeutic agent for modulating these COVID-19-related targets. The gene discussed is ACE; the disease is COVID-19.